We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
(-3.3%)
Cap. Flow
+$3.24B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.25B |
| 2 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$938M |
| 3 |
Apple
AAPL
|
+$911M |
| 4 |
Costco
COST
|
+$878M |
| 5 |
NVIDIA
NVDA
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.69B |
| 2 |
ServiceNow
NOW
|
+$651M |
| 3 |
Applied Materials
AMAT
|
+$563M |
| 4 |
Visa
V
|
+$536M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$523M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Financials | 11.41% |
| 3 | Consumer Discretionary | 10.18% |
| 4 | Industrials | 9.65% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Intapp
INTA
$2.12B
| $11.9M | ﹤0.01% |
463,796
+32,901
| +8% | +$981K |
|
1427
Compañía de Minas Buenaventura
BVN
$7.85B
| $11.9M | ﹤0.01% |
330,518
-3,000
| -0.9% | -$108K |
|
|
CALY
1428
Callaway Golf Company
CALY
$3.26B
| $11.9M | ﹤0.01% |
855,624
+377,915
| +79% | +$5.3M |
|
|
CAI
1429
Caris Life Sciences
CAI
$4.39B
| $11.9M | ﹤0.01% |
663,578
+641,165
| +2,861% | +$14M |
|
1430
Rogers Communications
RCI
$17.7B
| $11.9M | ﹤0.01% |
309,337
| – | – |
|
1431
Lear
LEA
$7.19B
| $11.9M | ﹤0.01% |
97,941
+1,506
| +2% | +$188K |
|
|
AMRZ
1432
Amrize Ltd
AMRZ
$27.3B
| $11.9M | ﹤0.01% |
212,990
+179,584
| +538% | +$10.3M |
|
1433
National Vision
EYE
$1.6B
| $11.8M | ﹤0.01% |
457,278
+211,155
| +86% | +$5.74M |
|
1434
Viridian Therapeutics
VRDN
$2.13B
| $11.8M | ﹤0.01% |
604,914
-137,423
| -19% | -$4.08M |
|
1435
Flywire
FLYW
$1.96B
| $11.8M | ﹤0.01% |
1,014,766
+18,084
| +2% | +$228K |
|
1436
Iridium Communications
IRDM
$4.85B
| $11.8M | ﹤0.01% |
425,145
-174,255
| -29% | -$3.92M |
|
1437
CarMax
KMX
$8.27B
| $11.8M | ﹤0.01% |
283,360
+29,024
| +11% | +$1.27M |
|
1438
Photronics
PLAB
$1.79B
| $11.8M | ﹤0.01% |
291,494
+162,848
| +127% | +$5.89M |
|
1439
Construction Partners
ROAD
$5.84B
| $11.7M | ﹤0.01% |
104,939
-2,740
| -3% | -$328K |
|
1440
Ituran Location and Control
ITRN
$1.08B
| $11.7M | ﹤0.01% |
237,752
+133,562
| +128% | +$6.29M |
|
1441
REX American Resources
REX
$1.46B
| $11.6M | ﹤0.01% |
254,321
-16,635
| -6% | -$603K |
|
1442
Cactus
WHD
$3.83B
| $11.6M | ﹤0.01% |
244,357
+29,984
| +14% | +$1.57M |
|
1443
Antero Midstream
AM
$10.8B
| $11.5M | ﹤0.01% |
505,000
-504,208
| -50% | -$10.4M |
|
1444
UFP Industries
UFPI
$4.97B
| $11.5M | ﹤0.01% |
124,374
+1,497
| +1% | +$151K |
|
1445
OneSpaWorld
OSW
$2.67B
| $11.5M | ﹤0.01% |
499,079
-82,614
| -14% | -$1.76M |
|
1446
Cullinan Oncology
CGEM
$1.05B
| $11.4M | ﹤0.01% |
805,700
+226,605
| +39% | +$2.91M |
|
1447
Campbell Soup
CPB
$6.51B
| $11.4M | ﹤0.01% |
514,058
+74,235
| +17% | +$1.91M |
|
1448
Warrior Met Coal
HCC
$4.23B
| $11.4M | ﹤0.01% |
122,824
+1,150
| +0.9% | +$104K |
|
1449
ICU Medical
ICUI
$3.93B
| $11.4M | ﹤0.01% |
88,511
-30,960
| -26% | -$4.45M |
|
1450
Moelis & Co
MC
$4.98B
| $11.4M | ﹤0.01% |
200,481
-13,117
| -6% | -$853K |
|
Similar funds
VFT
Nuveen's Q1 2026 Portfolio in Review
As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
- Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
- Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
- Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
- Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
- Nuveen opened 48 new positions and closed 76 in Q1 2026.
- Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.